Study to Evaluate the Immunogenicity, Reatogenicity and Safety of Double Viral Vaccine (MR) for Measles and Rubella
Clinical trial NCT03148990 · COMPLETED
Trial details
- NCT number
- NCT03148990
- Sponsor
- The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-20
- Primary completion
- 2020-08-12
- Enrollment
- 432
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.